![]() |
市场调查报告书
商品编码
1913360
压迫疗法市场机会、成长要素、产业趋势分析及2026年至2035年预测Compression Therapy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
全球压迫疗法市场预计到 2025 年将达到 39 亿美元,到 2035 年将达到 65 亿美元,年复合成长率为 5.1%。

推动该市场成长的因素包括静脉疾病盛行率上升、人们对现有治疗方案的认知度提高以及运动相关损伤和事故的增加。居家医疗解决方案的扩展、对非侵入性治疗方法需求的增长以及整形外科手术和术后护理的激增也进一步推动了市场成长。设备方面的技术创新、材料的改进以及以患者为中心的设计正在改善治疗效果。压迫疗法正日益成为运动员和復健专业人员促进復原和改善活动能力的首选。随着专业和休閒运动参与度的提高,预计压力解决方案在復健、提升运动表现和预防伤害方面的应用将推动全球医疗保健和运动医学领域的持续成长。
| 市场覆盖范围 | |
|---|---|
| 开始年份 | 2025 |
| 预测年份 | 2026-2035 |
| 起始值 | 39亿美元 |
| 预测金额 | 65亿美元 |
| 复合年增长率 | 5.1% |
截至2025年,压力服市占率达48.8%。压力服,包括长筒袜、袖套和紧身裤,提供从脚踝处压力最大并向上逐渐减弱的梯度压力,有助于促进血液循环、减轻肿胀并预防血栓形成。人们对淋巴水肿、深层静脉栓塞症栓塞(DVT)和术后恢復的日益关注推动了该领域的需求。现代设计着重于舒适性、透气性和美观性,进而提高患者的依从性和延长穿着时间。
2025年,静态压迫疗法市场规模预计将达33亿美元。这种疗法透过服装、绷带和固定装置对患处施加持续压力,以改善淋巴排放和血液循环。它广泛应用于慢性静脉疾病、术后康復和损伤康復,有助于促进癒合和恢復活动能力。
预计到2025年,北美压迫疗法市占率将达到32.1%。该地区受益于先进的医疗基础设施、完善的报销政策以及非侵入性治疗方法的广泛接受度。静脉疾病、淋巴水肿和深层静脉栓塞症(DVT)的高发生率,加上人口老化和肥胖率上升,持续推动临床和居家照护环境中对压力服和气动装置的需求。
The Global Compression Therapy Market was valued at USD 3.9 billion in 2025 and is estimated to grow at a CAGR of 5.1% to reach USD 6.5 billion by 2035.

The market is fueled by the rising prevalence of venous disorders, increased awareness of available treatment options, and a growing number of sports-related injuries and accidents. Expansion in home healthcare solutions, rising demand for non-invasive therapies, and a surge in orthopedic and post-surgical procedures are further driving growth. Technological innovations in devices, improved materials, and patient-centric designs are enhancing treatment efficacy. Athletes and rehabilitation professionals increasingly prefer compression therapy for faster recovery and improved mobility. As professional and recreational sports participation grows, the adoption of compression solutions for healing, performance, and injury prevention is expected to provide sustained momentum across medical and sports medicine applications globally.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $3.9 Billion |
| Forecast Value | $6.5 Billion |
| CAGR | 5.1% |
The compression garments segment held 48.8% share in 2025. These garments, including stockings, sleeves, and tights, provide graduated pressure, highest at the ankle and gradually reducing upward, to enhance blood circulation, reduce swelling, and prevent clot formation. Rising cases of lymphedema, deep vein thrombosis (DVT), and postoperative recovery needs are driving segmental demand. Modern designs emphasize comfort, breathability, and aesthetics, ensuring higher patient compliance and prolonged use.
The static compression therapy segment reached USD 3.3 billion in 2025. This therapy delivers continuous pressure through garments, wraps, or bandages over affected areas, improving lymphatic drainage and blood flow. It is widely applied in chronic venous disorders, post-surgical recovery, and injury rehabilitation to accelerate healing and restore mobility.
North America Compression Therapy Market held 32.1% share in 2025. The region benefits from advanced healthcare infrastructure, strong insurance reimbursement policies, and widespread acceptance of non-invasive treatment options. High prevalence of venous disorders, lymphedema, and DVT, along with an aging population and rising obesity rates, continues to drive demand for compression garments and pneumatic devices in both clinical and home care settings.
Key companies operating in the Global Compression Therapy Market include Tactile Medical, Smith+Nephew, ALCARE, Arjo, Bio Compression Systems, Cardinal Health, ConvaTec, Enovis, Essity, HARTMANN, Juzo, Medi, SANYLEG, SIGVARIS GROUP, and Solventum. Companies in the Global Compression Therapy Market are strengthening their position through several strategic initiatives. They focus on continuous product innovation, integrating smart technologies and advanced materials to improve comfort, durability, and therapeutic effectiveness. Geographic expansion enables access to emerging markets, while collaborations with healthcare providers and rehabilitation centers enhance product adoption. Firms are also emphasizing affordability and customizable solutions to cater to diverse patient needs.